Unravelling the Potential of Herbal Therapy for Polycystic Ovarian Disorder

Jump To References Section

Authors

  • Kangkana Sharma
     Department of Zoology, Gauhati University, Guwahati - 781014, Assam ,IN
  • Nuri Farzina Rahman
     Rahman Institute of Pharmaceutical Sciences and Research, Tepesia, Sonapur - 782402, Assam ,IN
  • Sahaniyaz Laskar
     Rahman Institute of Pharmaceutical Sciences and Research, Tepesia, Sonapur - 782402, Assam ,IN
  • Sahjahan Ali
     Rahman Institute of Pharmaceutical Sciences and Research, Tepesia, Sonapur - 782402, Assam ,IN
  • Md. A. Ahmed
     Rahman Institute of Pharmaceutical Sciences and Research, Tepesia, Sonapur - 782402, Assam ,IN
  • Wearank Terang
     Rahman Institute of Pharmaceutical Sciences and Research, Tepesia, Sonapur - 782402, Assam ,IN
  • Ningthoujam Dabung Meitei
     Rahman Institute of Pharmaceutical Sciences and Research, Tepesia, Sonapur - 782402, Assam ,IN
  • Haider Khan
     Rahman Institute of Pharmaceutical Sciences and Research, Tepesia, Sonapur - 782402, Assam ,IN
  • Md. Iliyash Ahamad
     Rahman Institute of Pharmaceutical Sciences and Research, Tepesia, Sonapur - 782402, Assam ,IN
  • Akshay Kumar Haloi
     Department of Zoology, Bhattadev University, Bajali, Barpeta - 781325, Assam ,IN
  • Rituraj Bharadwaj
     Rahman Institute of Pharmaceutical Sciences and Research, Tepesia, Sonapur - 782402, Assam ,IN

DOI:

https://doi.org/10.18311/jnr/2024/34761

Keywords:

Current Therapy, Environmental Factors, Genetic Factors, Herbal Therapy, Polycystic Ovarian Disorders

Abstract

Polycystic Ovarian Disorder is among the most well-known hormonal diseases influencing many women overall prompting the development of cysts on the ovaries. Albeit, the specific ground for its improvement isn’t very much revealed till now, however a mix of hereditary, ecological and way of life factors were considered as noticeable contributing variables for its development and advancement. The ongoing treatments for polycystic ovarian disorder incorporate a way of life alteration, utilization of oral contraceptives, anti-androgen therapy and insulin-sensitizing agents, ovulation induction and assisted reproductive technologies. Even though these ongoing treatments are well dependent to some degree in females enduring polycystic ovarian issues, various secondary effects are being accounted for to be related to these treatments. Herbal treatment could be an option for polycystic ovarian problems as it offers compelling recuperation with immaterial aftereffects. Herbal treatment frequently focuses on the main driver of the sickness instead of alleviating symptoms, expecting to re-establish general well-being and prosperity. In this ongoing review, we have compiled the purposes of specific spices for the treatment of polycystic ovarian disorders including cinnamon, fenugreek, gymnema, saw palmetto, spearmint, liquorice, turmeric and berberine - containing plants. These plants were accounted for too effective against polycystic ovarian disorder with their system of activity as portrayed. Escalated research on these plants will clear many new courses towards the advancement of medication disclosure and medication plans for the powerful treatment of polycystic ovarian issues.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Downloads

Published

2024-01-01

How to Cite

Sharma, K., Nuri Farzina Rahman, Sahaniyaz Laskar, Sahjahan Ali, Md. A. Ahmed, Wearank Terang, Ningthoujam Dabung Meitei, Haider Khan, Md. Iliyash Ahamad, Akshay Kumar Haloi, & Rituraj Bharadwaj. (2024). Unravelling the Potential of Herbal Therapy for Polycystic Ovarian Disorder. Journal of Natural Remedies, 24(1), 1–13. https://doi.org/10.18311/jnr/2024/34761

Issue

Volume 24, Issue 1, January 2024

Section

Review Articles

Categories

License

Copyright (c) 2023 Kangkana Sharma, Nuri Farzina Rahman, Sahaniyaz Laskar, Sahjahan Ali, Md. A. Ahmed, Wearank Terang, Ningthoujam Dabung Meitei, Haider Khan, Md. Iliyash Ahamad, Akshay Kumar Haloi, Rituraj Bharadwaj (Author)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC
Received 2023-08-16
Accepted 2023-09-25
Published 2024-01-01

 

References

Day F, Karaderi T, Jones MR, et al. Large-scale genomewide meta-analysis of polycystic ovary syndrome suggests a shared genetic architecture for different diagnosis criteria. PLOS Genet. 2018; 14(12):e1007813. https://doi.org/10.1371/ journal.pgen.1007813 PMid:30566500 PMCid:PMC6300389

Khan MJ, Ullah A, Basit S. Genetic basis of Polycystic Ovary Syndrome (PCOS): current perspectives. Appl Clin Genet. 2019; 12:249-60. https://doi.org/10.2147/TACG.S200341 PMid:31920361 PMCid:PMC6935309

Rosenfield RL, Ehrmann DA. The pathogenesis of Polycystic Ovary Syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016; 37(5):467-520. https://doi.org/10.1210/er.2015-1104 PMid:27459230 PMCid:PMC5045492

Govind A, Obhrai MS, Clayton RN. Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab. 1999; 84(1):38-43. https://doi. org/10.1210/jcem.84.1.5382 PMid:9920059

Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JS, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and Molecular Genetics of polycystic ovary syndrome. Endocr Rev. 2015; 36(5):487-525. https://doi.org/10.1210/er.2015-1018 PMid:26426951 PMCid:PMC4591526

Legro R. Insulin resistance in polycystic ovary syndrome. Curr Diab Rep. 2012; 12(2):179-84.

Palomba S, et al. Effect of weight loss on the cardiovascular system in obese women with polycystic ovary syndrome. Climacteric. 2017; 20(5):441-7.

Samimi M, et al. The role of oxidative stress and antioxidants in the female reproductive system and preeclampsia. J Cell Biochem. 2019; 120(6):8720-30.

Moran LJ, Hutchison SK, Norman RJ, Teede HJ. Lifestyle changes in women with polycystic ovary syndrome. Cochrane Database Syst Rev. 2013; 1:CD007506. https:// doi.org/10.1002/14651858.CD007506.pub3

Azziz R, et al. Oral contraceptive pill in Polycystic Ovary Syndrome (PCOS): a 31-year retrospective study in 1,385 women. J Clin Endocrinol Metab. 2018; 103(5):1704-14.

Muhlemann M, et al. Use of cyproterone acetate/ethinyl estradiol in polycystic ovary syndrome: rationale and practical aspects. Drugs. 2019; 79(14):1535-46.

Palomba S, et al. Metformin in the treatment of moderate to severe acne in patients with polycystic ovary syndrome: a randomized controlled trial. Hum Reprod. 2015; 30(12):2876-84. https://doi.org/10.1186/1477-7827-12-3 PMid:24387273 PMCid:PMC3895676

Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018; 33(9):1602-18. https://doi.org/10.1093/ humrep/dey256 PMid:30052961 PMCid:PMC6112576

Palomba S, et al. Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review. Reprod Biol Endocrinol.2020; 18(1):3. https://doi.org/10.1186/1477-7827-12-3 PMid:24387273 PMCid:PMC3895676

Rao PV, Gan SH. Cinnamon: A multifaceted medicinal plant. Evid Based Complement Alternat Med. 2014; 2014:642942. https://doi.org/10.1155/2014/642942 PMid: 24817901 PMCid:PMC4003790

Kim DH. Chemical constituents of Cassia cinnamon and their pharmacological activities against human diseases. Evid Based Complement Alternat Med. 2018; 2018:4906410.

Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med. 2013; 11(5):452-9. https://doi.org/10.1370/afm.1517PMid:24019277 PMCid:PMC3767714

Anderson RA, Zhan Z, Luo R, et al. Cinnamon extract lowers glucose, insulin, and cholesterol in people with elevated serum glucose. J Tradit Complement Med. 2016; 6(4):332-6. https://doi.org/10.1016/j.jtcme.2015.03.005 PMid:27774415 PMCid:PMC5067830

Bhatti R, et al. Cinnamon supplementation improves metabolic parameters and menstrual cyclicity in women with polycystic ovary syndrome. J Funct Foods. 2018; 41:277-83.

Gao Q, et al. Cinnamaldehyde improves glucose metabolism and insulin sensitivity by repressing endoplasmic reticulum stress in PCOS. Life Sci. 2019; 239:117012.

Karimzadeh-Bardei L, et al. The effect of cinnamon supplementation on anthropometric indices and glycemic status in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Complement Ther. Clin Pract. 2020; 39:101156.

Zadeh Modarres S, et al. Effects of cinnamon supplementation on antioxidant status and serum lipids in women with polycystic ovary syndrome. J Sci Food Agric. 2020; 100(9):3893-9.

Al-Snafi AE. Fenugreek (Trigonella foenum-graecum L.): a review. Int J Pharm Res Allied Sci. 2015; 4(3):90-5.

Rafraf M, Keshtkar A, Nourieh Z. Effects of fenugreek seeds on postprandial glucose, insulin, and triglyceride in patients with type 2 diabetes mellitus. Int J Vitam Nutr Res. 2009; 79(1):34-9. https://doi.org/10.1024/0300-9831.79.1.34 PMid:19839001

Sharma RD, Raghuram TC, Rao NS. Effect of fenugreek seeds on blood glucose and serum lipids in type I diabetes. Eur J Clin Nutr. 1990; 44(4):301-6.

Ebrahimi-Mameghani M, et al. The effect of fenugreek on insulin resistance and lipid profile in polycystic ovary syndrome: A double-blind, randomized trial. Eur J Clin Nutr. 2017; 71(1):54-60.

Roshanzamir F, et al. The effect of fenugreek [Trigonella foenum-graecum L] seed extract on insulin resistance in women with polycystic ovary syndrome: A double-blind randomized placebo-controlled trial. Phytother Res. 2019; 33(5):1330-40.

Younesy S, Amiraliakbari S, Esmaeili S, Alavimajd H, Nouraei S. Effects of fenugreek seed on the severity and systemic symptoms of dysmenorrhea. J Reprod Infertil. 2014; 15(1):41-8.

Al-Romaiyan A, Liu B, Asare-Anane H, et al. A novel Gymnema sylvestre extract stimulates insulin secretion from human islets in vivo and in vitro. Phytother Res. 2010; 24(9):1370-6. https://doi.org/10.1002/ptr.3125 PMid:20812281

Baskaran K, Kizar Ahamath B, Radha Shanmugasundaram K, Shanmugasundaram ER. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. J Ethnopharmacol. 1990; 30(3):295-300. https://doi.org/10.1016/0378-8741(90)90108- 6PMid:2259217

Okabayashi Y, Tani S, Fujisawa T, et al. Effect of Gymnema sylvestre, R.Br. on glucose homeostasis in rats. Diabetes Res Clin Pract. 1990; 9(2):143-8. https://doi.org/10.1016/0168- 8227(90)90106-4 PMid:1695875

Kumar SN, Mani UV, Mani I. An open-label study on the supplementation of Gymnema sylvestre in type 2 diabetics. J Diet Suppl. 2010; 7(3):273-82. https://doi.org/10.3109/19390211.2010.505901 PMid:22432517

Persaud SJ, Al-Majed H, Raman A, Jones PM. Gymnema sylvestre stimulates insulin release in vitro by increasing membrane permeability. J Endocrinol. 1999; 163(2):207-12. https://doi.org/10.1677/joe.0.1630207 PMid:10556769

Baskaran K, Kizar Ahamath B, Radha Shanmugasundaram K, Shanmugasundaram ER. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulindependent diabetes mellitus patients. J Ethnopharmacol. 1990; 30(3):295-300. https://doi.org/10.1016/0378- 8741(90)90108-6 PMid:2259217

MahendranP, et al. Effectof Gymnema sylvestre, R.Br. inthecontrol of diabetes mellitus—a clinical trial. J Ethnopharmacol. 1990; 30(3):281-94. https://doi.org/10.1016/0378-8741(90)90107-5 PMid:2259216

Kamenov Z, et al. Effects of an extract from Gymnema sylvestre on glucose homeostasis in rats with alloxan diabetes. Acta Physiol Pharmacol Bulg. 1990; 16(2):25-30.

Al-Romaiyan A, Liu B, Asare-Anane H, et al. A novel Gymnema sylvestre extract stimulates insulin secretion from human islets in vivo and in vitro. Phytother Res. 2010; 24(9):1370-6. https://doi.org/10.1002/ptr.3125PMid:20812281

Bent S, Kane C, Shinohara K, et al. Saw palmetto for benign prostatic hyperplasia. N Engl J Med. 2006; 354(6):557-66. https://doi.org/10.1056/NEJMoa053085 PMid:16467543

Gerber GS, Kuznetsov D, Johnson BC, Burstein JD. Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms. Urology. 2001; 58(6):960-4. https://doi.org/10.1016/S0090-4295(01)01442-X PMid:11744467

Rossi A, Mari E, Scarno M, et al. Comparative effectiveness of finasteride vs Serenoa repens in male androgenetic alopecia: A two-year study. Int J Immunopathol Pharmacol. 2012; 25(4):1167-73. https://doi.org/10.1177/039463201202500435 PMid:23298508

Golechha M. Therapeutic potential of saw palmetto and its constituents: a review. Naunyn Schmiedebergs Arch Pharmacol. 2013; 386(4):331-8.

Grant P, Ramasamy S. An update on plant-derived antiandrogens. Int J Endocrinol Metab. 2012; 10(2):497-502. https://doi.org/10.5812/ijem.3644 PMid:23843810 PMCid: PMC3693613

Prager N, Bickett K, French N, Marcovici G. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia. J Altern Complement Med. 2002; 8(2):143-52. https://doi.org/10.1089/acm.2002.8.143 PMid:12006122

Maleki-Saghooni N, Mirzaeii K, Hosseinzadeh H, Sadeghi R, Irani M. A systematic review and meta-analysis of clinical trials on saffron (Crocus sativus) effectiveness and safety on erectile dysfunction and semen parameters. Avicenna J Phytomed. 2018; 8(3):198-209.

McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother Res. 2006; 20(8):619-33. https://doi. org/10.1002/ptr.1936 PMid:16767798

Koulivand PH, Khaleghi Ghadiri M, Gorji A. Lavender and the nervous system. Evid Based Complement Alternat Med. 2013; 2013:681304. https://doi.org/10.1155/2013/681304 PMid:23573142 PMCid:PMC3612440

Prakash B, Singh P, Yadav PK, Dubey NK. Safety assessment of essential oil constituents: use of essential oil constituents as food additives. Food Chem Toxicol. 2017; 110:251-63.

Grant P. Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial. Phytother Res. 2010; 24(2):186-8. https:// doi.org/10.1002/ptr.2900 PMid:19585478

Akdoğan M, Tamer MN, Cüre E, Cüre MC, Köroğlu BK, Delibaş N. Investigation of the effect of spearmint (Mentha spicata) on the androgenic hormone levels in polycystic ovary syndrome patients. Phytother Res. 2007; 21(5):444-7. https://doi.org/10.1002/ptr.2074 PMid:17310494

Grant P. Spearmint herbal tea has significant anti-androgen effects in polycystic ovarian syndrome. A randomized controlled trial. Phytother Res. 2010; 24(2):186-8. https:// doi.org/10.1002/ptr.2900 PMid:19585478

Moeini R, et al. Effect of spearmint on symptoms of polycystic ovarian syndrome. Iran J Reprod Med. 2013; 11(8):665-72.

Kashefi F, et al. Comparison of the therapeutic effects of three herbal medicines on the metabolic profiles of women with polycystic ovary syndrome. Chin J Integr Med. 2015; 21(8):607-12.

Shamsa F, Ahmadiani A, Khosrokhavar R. Antihistaminic and anticholinergic activity of liquorice roots (Glycyrrhiza glabra). Iran J Pharm Res. 2003; 2(1):43-7.

Morgan AG, McAdam WAF, Pacsoo C, Darnborough A. Comparison between cimetidine and Caved-S in the treatment of gastric ulceration, and subsequent maintenance therapy. Gut. 1982; 23(6):545-51. https://doi.org/10.1136/ gut.23.6.545 PMid:7042486 PMCid:PMC1419696

Yang R, Yuan B, Ma Y, Zhou S. Pharmacological activities of triterpenoids from the genus Glycyrrhiza. Mini Rev Med Chem. 2018; 18(11):953-68.

Armanini D, Bonanni G, Mattarello MJ, Fiore C, Sartorato P, Palermo M. Liquorice consumption and serum testosterone in healthy man. Exp Clin Endocrinol Diabetes. 2003; 111(6):341-3. https://doi.org/10.1055/s-2003-42724 PMid:14520600

Armanini D, Mattarello MJ, Fiore C, et al. Liquorice reduces serum testosterone in healthy women. Steroids. 2004; 69(11- 12):763-6. https://doi.org/10.1016/j.steroids.2004.09.005 PMid:15579328

Arentz S, Abbott JA, Smith CA, Bensoussan A. Herbal medicine for the management of Polycystic Ovary Syndrome (PCOS) and associated oligo/amenorrhoea and hyperandrogenism; a review of the laboratory evidence for effects with corroborative clinical findings. BMC Complement Altern Med. 2014; 14:511. https://doi. org/10.1186/1472-6882-14-511 PMid:25524718 PMCid: PMC4528347

Radha R, et al. Effect of Glycyrrhiza glabra Linn root extract on estradiol-induced polycystic ovarian syndrome in rats. Int J Appl Basic Med Res. 2017; 7(3):159-64.

Jagetia GC, Aggarwal BB. ‘Spicing up’ of the immune system by curcumin. J Clin Immunol. 2007; 27(1):19-35. https:// doi.org/10.1007/s10875-006-9066-7 PMid:17211725

Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev. 2009; 14(2):141-53.

Armanini D, et al. Curcumin supplementation and hormonal profiles in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial. Phytother Res. 2015; 29(4):575-9.

Ejaz S, et al. Effect of curcumin on insulin resistance in adipose tissue of obese rats. Phytother Res. 2009; 23(3):347-50.

Khani B, et al. Effect of curcumin on insulin resistance, inflammatory biomarkers, and oxidative stress in women with polycystic ovary syndrome: A randomized, doubleblind, placebo-controlled trial. Phytother Res. 2020; 34(10):2686-93.

Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008; 57(5):712-7. https://doi. org/10.1016/j.metabol.2008.01.013 PMid:18442638 PMCid: PMC2410097

Dong H, Wang N, Zhao L, Lu F. Berberine in the treatment of type 2 diabetes mellitus: A systemic review and metaanalysis. Evid Based Complement Alternat Med. 2012; 2012:591654. https://doi.org/10.1155/2012/591654 PMid: 23118793 PMCid:PMC3478874

Xu D, Hu MJ, Wang YQ, Cui YL. Antidiarrheal effects of alkaloids from Coptidis rhizome on experimental mice. Fitoterapia. 2012; 83(4):729-35. https://doi.org/10.1016/j. fitote.2012.04.023 PMid:22579843

Chen Y, Zheng Z, Wang J, et al. Berberine suppresses apoptosis and extracellular matrix degradation in nucleus pulposus cells and ameliorates disc degeneration in a rodent model. Int J Biol Sci. 2018; 14(6):682-92. https://doi.org/10.7150/ ijbs.24081 PMid:29904282 PMCid:PMC6001656

Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab. 2008; 93(7):2559-65. https://doi. org/10.1210/jc.2007-2404 PMid:18397984

Ivanovska N, Philipov S. Study on the anti-inflammatory action of Berberis vulgaris root extract, alkaloid fractions and pure alkaloids. Int J Immunopharmacol. 1996; 18(10): 553-61. https://doi.org/10.1016/S0192-0561(96)00047-1 PMid:9080249

Yin J, Xing H, Ye J. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism. 2008; 57(5):712-7. https:// doi.org/10.1016/j.metabol.2008.01.013 PMid:18442638 PMCid:PMC2410097

Orecchio S, et al. The use of berberine to improve the efficacy of letrozole in overweight women with PCOS undergoing IVF cycles. J Assist Reprod Genet. 2015; 32(7):1111-8.

Mirzaei K, et al. A double-blind, randomized, placebocontrolled trial of berberine effects on the menstrual pattern, ovulation rate, and hormonal profile in women with polycystic ovary syndrome. J Res Med Sci. 2018; 23:9.

Wuttke W, Jarry H, Christoffel V, Spengler B, Seidlová- Wuttke D. Chaste tree (Vitex agnus-castus)–pharmacology and clinical indications. Phytomedicine. 2003; 10(4):348- 57. https://doi.org/10.1078/094471103322004866 PMid: 12809367 75. van Die MD, Bone KM, Burger HG, Reece JE, Teede HJ. Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in lateperimenopausal women: findings from a subpopulation analysis. J Altern Complement Med. 2009; 15(9):1045-8. https://doi.org/10.1089/acm.2008.0539 PMid:19757982

Loch EG, Selle H, Boblitz N. Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus. J Womens Health Gend Based Med. 2000; 9(3):315-20. https://doi.org/10.1089/152460900318515 PMid:10787228

Huddleston HG, Jackson KS, Tangpricha V, White WM, Conway-Williams E. Outcomes of treatment of patients with hyperandrogenism, menstrual irregularities, and polycystic ovary syndrome. Am J Obstet Gynecol. 2002; 187(6):181-7.

Banoth M, Naru RR, Inamdar MB, Chowhan AK. Familial Swyer syndrome: a rare genetic entity. Gynecol Endocrinol. 2018; 34(5):389-93. https://doi.org/10.1080/09513590.2017 .1393662 PMid:29069951

van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus (Chaste-Tree/Berry) in the treatment of menopause-related complaints. J Altern Complement Med. 2009; 15(8):853-62. https://doi.org/10.1089/acm. 2008.0447 PMid:19678775

Halaska M, Beles P, Gorkow C, Sieder C. Treatment of cyclical mastalgia with a solution containing a Vitex agnus castus extract: results of a placebo-controlled double-blind study. Breast. 1999; 8(4):175-81. https://doi.org/10.1054/ brst.1999.0039 PMid:14731436

Carmichael AR. Can Vitex agnus castus be used for the treatment of mastalgia? What is the Current Evidence? Evid Based Complement Alternat Med. 2008; 5(3):247- 50. https://doi.org/10.1093/ecam/nem074 PMid:18830450 PMCid:PMC2529385

Most read articles by the same author(s)